Conventional second-line therapy Clinical Trials
2 recruitingCombination Product
Not Applicable2
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751914
Recruiting
Not Applicable
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751940